SHARES PLUMMETS AFTER NOVO NORDISK DEAL BREAKDOWN

Shares of HIMS experienced a dramatic drop today following the unexpected termination of its agreement with pharmaceutical giant Novo Nordisk. Investors responded negatively to the news, sending the company's stock price plummeting by more than 20%. The reason for the collapse of the partnership remains unclear, but industry analysts speculate that